<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37606042</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>B cell-intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e172219</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.172219</ELocationID><Abstract><AbstractText>The endosomal Toll-like receptor 7 (TLR7) is a major driver of murine and human systemic lupus erythematosus (SLE). The role of TLR7 in lupus pathogenesis is enhanced when the regulatory role of TLR9 is absent. TLR7 signaling in plasmacytoid DCs (pDC) is generally thought to be a major driver of the IFN response and disease pathology; however, the cell types in which TLR7 acts to mediate disease have not been distinguished. To address this, we selectively deleted TLR7 in either CD11c+ cells or CD19+ cells; using a TLR7-floxed allele, we created on the lupus-prone MRL/lpr background, along with a BM chimera strategy. Unexpectedly, TLR7 deficiency in CD11c+ cells had no impact on disease, while TLR7 deficiency in CD19+ B cells yielded mild suppression of proteinuria and a trend toward reduced glomerular disease. However, in TLR9-deficient MRL/lpr mice with accelerated SLE, B cell-specific TLR7 deficiency greatly improved disease. These results support revision of the mechanism by which TLR7 drives lupus and highlight a cis regulatory interaction between the protective TLR9 and the pathogenic TLR7 within the B cell compartment. They suggest B cell-directed, dual TLR7 antagonism/TLR9 agonism or dual TLR7/9 antagonism as a potential future therapeutic strategy to treat SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cosgrove</LastName><ForeName>Haylee A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Immunology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gingras</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Immunology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minjung</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastacky</LastName><ForeName>Sheldon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tilstra</LastName><ForeName>Jeremy S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Immunology.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shlomchik</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Immunology.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 AR077989</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 AR075056</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR001856</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AI118841</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051199">Toll-Like Receptor 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051217">Toll-Like Receptor 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495348">TLR7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495371">TLR9 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051199" MajorTopicYN="N">Toll-Like Receptor 7</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051217" MajorTopicYN="N">Toll-Like Receptor 9</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000361" MajorTopicYN="Y">Agammaglobulinemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune diseases</Keyword><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Innate immunity</Keyword><Keyword MajorTopicYN="N">Lupus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>7</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37606042</ArticleId><ArticleId IdType="pmc">PMC10543715</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.172219</ArticleId><ArticleId IdType="pii">172219</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC, et al. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716&#x2013;730. doi: 10.1038/nrrheum.2016.186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039. doi: 10.1038/nrdp.2016.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev. 2006;6(11):823&#x2013;842. doi: 10.1038/nri1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1957</ArticleId><ArticleId IdType="pubmed">15790348</ArticleId></ArticleIdList></Reference><Reference><Citation>Heil F, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303(5663):1526&#x2013;1529. doi: 10.1126/science.1093620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1093620</ArticleId><ArticleId IdType="pubmed">14976262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmi H, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408(6813):740&#x2013;745. doi: 10.1038/35047123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35047123</ArticleId><ArticleId IdType="pubmed">11130078</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester SN, et al. Toll-like receptors in antiviral innate immunity. J Mol Biol. 2014;426(6):1246&#x2013;1264. doi: 10.1016/j.jmb.2013.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.11.024</ArticleId><ArticleId IdType="pmc">PMC3943763</ArticleId><ArticleId IdType="pubmed">24316048</ArticleId></ArticleIdList></Reference><Reference><Citation>Richez C, et al. Role for Toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine. 2011;78(2):124&#x2013;130. doi: 10.1016/j.jbspin.2010.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2010.09.005</ArticleId><ArticleId IdType="pubmed">20961794</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad Hosseini A, et al. Toll-like receptors in the pathogenesis of autoimmune diseases. Adv Pharm Bull. 2015;5(suppl 1):605&#x2013;614. doi: 10.15171/apb.2015.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/apb.2015.082</ArticleId><ArticleId IdType="pmc">PMC4708030</ArticleId><ArticleId IdType="pubmed">26793605</ArticleId></ArticleIdList></Reference><Reference><Citation>Leadbetter EA, et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416(6881):603&#x2013;607. doi: 10.1038/416603a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/416603a</ArticleId><ArticleId IdType="pubmed">11948342</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vgren T, et al. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004;50(6):1861&#x2013;1872. doi: 10.1002/art.20254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20254</ArticleId><ArticleId IdType="pubmed">15188363</ArticleId></ArticleIdList></Reference><Reference><Citation>Boul&#xe9; MW, et al. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med. 2004;199(12):1631&#x2013;1640. doi: 10.1084/jem.20031942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20031942</ArticleId><ArticleId IdType="pmc">PMC2212813</ArticleId><ArticleId IdType="pubmed">15197227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau CM, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med. 2005;202(9):1171&#x2013;1177. doi: 10.1084/jem.20050630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050630</ArticleId><ArticleId IdType="pmc">PMC2213226</ArticleId><ArticleId IdType="pubmed">16260486</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane JA, et al. Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 2007;27(5):801&#x2013;810. doi: 10.1016/j.immuni.2007.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.09.009</ArticleId><ArticleId IdType="pmc">PMC2706502</ArticleId><ArticleId IdType="pubmed">17997333</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairhurst AM, et al. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur J Immunol. 2008;38(7):1971&#x2013;1978. doi: 10.1002/eji.200838138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200838138</ArticleId><ArticleId IdType="pmc">PMC2993003</ArticleId><ArticleId IdType="pubmed">18521959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SH, et al. B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J Immunol. 2012;189(12):5786&#x2013;5796. doi: 10.4049/jimmunol.1202195.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202195</ArticleId><ArticleId IdType="pmc">PMC3544945</ArticleId><ArticleId IdType="pubmed">23150717</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris M, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol. 2018;3(19):eaap8855. doi: 10.1126/sciimmunol.aap8855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aap8855</ArticleId><ArticleId IdType="pubmed">29374079</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos B, et al. TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from Southern Brazil. Lupus. 2012;21(3):302&#x2013;309. doi: 10.1177/0961203311425522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311425522</ArticleId><ArticleId IdType="pubmed">22065095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CM, et al. Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population. Sci Rep. 2014;4:3792. doi: 10.1038/srep03792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep03792</ArticleId><ArticleId IdType="pmc">PMC3896912</ArticleId><ArticleId IdType="pubmed">24445780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, et al. Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update. Lupus. 2016;25(6):593&#x2013;601. doi: 10.1177/0961203315622823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315622823</ArticleId><ArticleId IdType="pubmed">26762473</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GJ, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605(7909):349&#x2013;356. doi: 10.1038/s41586-022-04642-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04642-z</ArticleId><ArticleId IdType="pmc">PMC9095492</ArticleId><ArticleId IdType="pubmed">35477763</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen SR, et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med. 2005;202(2):321&#x2013;331. doi: 10.1084/jem.20050338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050338</ArticleId><ArticleId IdType="pmc">PMC2212997</ArticleId><ArticleId IdType="pubmed">16027240</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen SR, et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25(3):417&#x2013;428. doi: 10.1016/j.immuni.2006.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.07.013</ArticleId><ArticleId IdType="pubmed">16973389</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickerson KM, et al. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol. 2010;184(4):1840&#x2013;1848. doi: 10.4049/jimmunol.0902592.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902592</ArticleId><ArticleId IdType="pmc">PMC4098568</ArticleId><ArticleId IdType="pubmed">20089701</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickerson K, et al. Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL mice. PLoS One. 2017;12(3):e0173471. doi: 10.1371/journal.pone.0173471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0173471</ArticleId><ArticleId IdType="pmc">PMC5344451</ArticleId><ArticleId IdType="pubmed">28278279</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilstra JS, et al. B cell-intrinsic TLR9 expression is protective in murine lupus. J Clin Invest. 2020;130(6):3172&#x2013;3187. doi: 10.1172/JCI132328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132328</ArticleId><ArticleId IdType="pmc">PMC7260024</ArticleId><ArticleId IdType="pubmed">32191633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lartigue A, et al. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J Immunol. 2006;177(2):1349&#x2013;1354. doi: 10.4049/jimmunol.177.2.1349.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.2.1349</ArticleId><ArticleId IdType="pubmed">16818796</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P, et al. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int Immunol. 2006;18(8):1211&#x2013;1219. doi: 10.1093/intimm/dxl067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxl067</ArticleId><ArticleId IdType="pubmed">16798839</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago-Raber ML, et al. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun. 2010;34(4):339&#x2013;348. doi: 10.1016/j.jaut.2009.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2009.11.001</ArticleId><ArticleId IdType="pubmed">19944565</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoehr AD, et al. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity. J Immunol. 2011;187(6):2953&#x2013;2965. doi: 10.4049/jimmunol.1003340.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003340</ArticleId><ArticleId IdType="pubmed">21859955</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SW, et al. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J Immunol. 2014;192(10):4525&#x2013;4532. doi: 10.4049/jimmunol.1400098.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400098</ArticleId><ArticleId IdType="pmc">PMC4041708</ArticleId><ArticleId IdType="pubmed">24711620</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossaller L, et al. TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus. J Immunol. 2016;197(4):1044&#x2013;1053. doi: 10.4049/jimmunol.1501943.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501943</ArticleId><ArticleId IdType="pmc">PMC5266544</ArticleId><ArticleId IdType="pubmed">27354219</ArticleId></ArticleIdList></Reference><Reference><Citation>Verthelyi D, et al. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 2003;24(10):519&#x2013;522. doi: 10.1016/S1471-4906(03)00243-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1471-4906(03)00243-6</ArticleId><ArticleId IdType="pubmed">14552833</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature. 2005;434(7036):1035&#x2013;1040. doi: 10.1038/nature03547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03547</ArticleId><ArticleId IdType="pubmed">15815647</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng SL. Signaling in B cells via Toll-like receptors. Curr Opin Immunol. 2005;17(3):230&#x2013;236. doi: 10.1016/j.coi.2005.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2005.03.003</ArticleId><ArticleId IdType="pubmed">15886111</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiducci C, et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med. 2006;203(8):1999&#x2013;2008. doi: 10.1084/jem.20060401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20060401</ArticleId><ArticleId IdType="pmc">PMC2118381</ArticleId><ArticleId IdType="pubmed">16864658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol. 2006;8(12):1327&#x2013;1336. doi: 10.1038/ncb1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1500</ArticleId><ArticleId IdType="pubmed">17128265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi A, et al. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity. 2008;28(6):799&#x2013;809. doi: 10.1016/j.immuni.2008.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.03.019</ArticleId><ArticleId IdType="pmc">PMC2601674</ArticleId><ArticleId IdType="pubmed">18513998</ArticleId></ArticleIdList></Reference><Reference><Citation>Shintani Y, et al. TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons. Proc Natl Acad Sci U S A. 2013;110(13):5109&#x2013;5114. doi: 10.1073/pnas.1219243110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219243110</ArticleId><ArticleId IdType="pmc">PMC3612600</ArticleId><ArticleId IdType="pubmed">23479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Avalos AM, et al. Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice. J Immunol. 2013;190(2):695&#x2013;702. doi: 10.4049/jimmunol.1202342.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202342</ArticleId><ArticleId IdType="pmc">PMC3539690</ArticleId><ArticleId IdType="pubmed">23241879</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Zayat SR, et al. Toll-like receptors activation, signaling, and targeting: an overview. Bull Natl Res Cent. 2019;43(1):187. doi: 10.1186/s42269-019-0227-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42269-019-0227-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibler C, et al. Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus. Nat Immunol. 2022;23(10):1457&#x2013;1469. doi: 10.1038/s41590-022-01310-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01310-2</ArticleId><ArticleId IdType="pmc">PMC9561083</ArticleId><ArticleId IdType="pubmed">36151396</ArticleId></ArticleIdList></Reference><Reference><Citation>Heng TS, et al. The immunological genome project: networks of gene expression in immune cells. Nat Immunol. 2008;9(10):1091&#x2013;1094. doi: 10.1038/ni1008-1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1008-1091</ArticleId><ArticleId IdType="pubmed">18800157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata K, et al. Up-regulation of TLR7-mediated IFN-&#x3b1; production by plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Front Immunol. 2018;9:1957. doi: 10.3389/fimmu.2018.01957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01957</ArticleId><ArticleId IdType="pmc">PMC6121190</ArticleId><ArticleId IdType="pubmed">30210502</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MK, et al. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity. 2003;36(8):481&#x2013;490. doi: 10.1080/08916930310001625952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930310001625952</ArticleId><ArticleId IdType="pubmed">14984025</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual V, et al. The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol. 2003;15(5):548&#x2013;556. doi: 10.1097/00002281-200309000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002281-200309000-00005</ArticleId><ArticleId IdType="pubmed">12960479</ArticleId></ArticleIdList></Reference><Reference><Citation>Celhar T, et al. RNA sensing by conventional dendritic cells is central to the development of lupus nephritis. Proc Natl Acad Sci U S A. 2015;112(45):E6195&#x2013;E6204. doi: 10.1073/pnas.1507052112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1507052112</ArticleId><ArticleId IdType="pmc">PMC4653170</ArticleId><ArticleId IdType="pubmed">26512111</ArticleId></ArticleIdList></Reference><Reference><Citation>Teichmann LL, et al. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity. 2013;38(3):528&#x2013;540. doi: 10.1016/j.immuni.2012.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.11.017</ArticleId><ArticleId IdType="pmc">PMC3638041</ArticleId><ArticleId IdType="pubmed">23499488</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker-Herman S, et al. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med. 2011;208(10):2033&#x2013;2042. doi: 10.1084/jem.20110200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20110200</ArticleId><ArticleId IdType="pmc">PMC3182055</ArticleId><ArticleId IdType="pubmed">21875954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolhatkar NS, et al. B-cell intrinsic TLR7 signals promote depletion of the marginal zone in a murine model of Wiskott-Aldrich syndrome. Eur J Immunol. 2015;45(10):2773&#x2013;2779. doi: 10.1002/eji.201545644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545644</ArticleId><ArticleId IdType="pmc">PMC4679197</ArticleId><ArticleId IdType="pubmed">26256668</ArticleId></ArticleIdList></Reference><Reference><Citation>Caton ML, et al. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med. 2007;204(7):1653&#x2013;1664. doi: 10.1084/jem.20062648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20062648</ArticleId><ArticleId IdType="pmc">PMC2118632</ArticleId><ArticleId IdType="pubmed">17591855</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, et al. CD11c-expressing B cells are located at the T cell/B cell border in spleen and are potent APCs. J Immunol. 2015;195(1):71&#x2013;79. doi: 10.4049/jimmunol.1500055.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500055</ArticleId><ArticleId IdType="pmc">PMC4475418</ArticleId><ArticleId IdType="pubmed">26034175</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood. 2011;118(5):1305&#x2013;1315. doi: 10.1182/blood-2011-01-331462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-331462</ArticleId><ArticleId IdType="pmc">PMC3152497</ArticleId><ArticleId IdType="pubmed">21543762</ArticleId></ArticleIdList></Reference><Reference><Citation>Racine R, et al. CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection. J Immunol. 2008;181(2):1375&#x2013;1385. doi: 10.4049/jimmunol.181.2.1375.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.2.1375</ArticleId><ArticleId IdType="pmc">PMC2645789</ArticleId><ArticleId IdType="pubmed">18606692</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard ML, et al. Mouse models of lupus: what they tell us and what they don&#x2019;t. Lupus Sci Med. 2018;5(1):e000199. doi: 10.1136/lupus-2016-000199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2016-000199</ArticleId><ArticleId IdType="pmc">PMC5786947</ArticleId><ArticleId IdType="pubmed">29387435</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, et al. TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice. Immunol Res. 2013;55(1&#x2013;3):210&#x2013;216. doi: 10.1007/s12026-012-8365-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-012-8365-8</ArticleId><ArticleId IdType="pmc">PMC3935605</ArticleId><ArticleId IdType="pubmed">22945807</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz I, et al. Challenges and opportunities for consistent classification of human B cell and plasma cell populations. Front Immunol. 2019;10:2458. doi: 10.3389/fimmu.2019.02458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02458</ArticleId><ArticleId IdType="pmc">PMC6813733</ArticleId><ArticleId IdType="pubmed">31681331</ArticleId></ArticleIdList></Reference><Reference><Citation>Giles JR, et al. B cell-specific MHC class II deletion reveals multiple nonredundant roles for B cell antigen presentation in murine lupus. J Immunol. 2015;195(6):2571&#x2013;2579. doi: 10.4049/jimmunol.1500792.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500792</ArticleId><ArticleId IdType="pmc">PMC4561209</ArticleId><ArticleId IdType="pubmed">26268653</ArticleId></ArticleIdList></Reference><Reference><Citation>Means TK, et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest. 2005;115(2):407&#x2013;417. doi: 10.1172/JCI23025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI23025</ArticleId><ArticleId IdType="pmc">PMC544604</ArticleId><ArticleId IdType="pubmed">15668740</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe5;ve U, et al. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol. 2003;171(6):3296&#x2013;3302. doi: 10.4049/jimmunol.171.6.3296.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.6.3296</ArticleId><ArticleId IdType="pubmed">12960360</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland SL, et al. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J Exp Med. 2014;211(10):1977&#x2013;1991. doi: 10.1084/jem.20132620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20132620</ArticleId><ArticleId IdType="pmc">PMC4172228</ArticleId><ArticleId IdType="pubmed">25180065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisirak V, et al. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med. 2014;211(10):1969&#x2013;1976. doi: 10.1084/jem.20132522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20132522</ArticleId><ArticleId IdType="pmc">PMC4172218</ArticleId><ArticleId IdType="pubmed">25180061</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xf6;hner M, et al. Molecular functions of the transcription factors E2A and E2-2 in controlling germinal center B cell and plasma cell development. J Exp Med. 2016;213(7):1201&#x2013;1221. doi: 10.1084/jem.20152002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20152002</ArticleId><ArticleId IdType="pmc">PMC4925024</ArticleId><ArticleId IdType="pubmed">27261530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilstra JS, et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J Clin Invest. 2018;128(11):4884&#x2013;4897. doi: 10.1172/JCI120859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI120859</ArticleId><ArticleId IdType="pmc">PMC6205402</ArticleId><ArticleId IdType="pubmed">30130253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, et al. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood. 2011;118(5):1294&#x2013;1304. doi: 10.1182/blood-2011-01-330530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-330530</ArticleId><ArticleId IdType="pmc">PMC3152496</ArticleId><ArticleId IdType="pubmed">21562046</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier S, et al. Mouse genome engineering via CRISPR-Cas9 for study of immune function. Immunity. 2015;42(1):18&#x2013;27. doi: 10.1016/j.immuni.2015.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.01.004</ArticleId><ArticleId IdType="pmc">PMC4720985</ArticleId><ArticleId IdType="pubmed">25607456</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell AM, et al. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci Transl Med. 2012;4(157):157ra141. doi: 10.1126/scitranslmed.3004801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004801</ArticleId><ArticleId IdType="pmc">PMC3704198</ArticleId><ArticleId IdType="pubmed">23100627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>